In 2023, humanitarian aid in Ukraine remained a key focus for Green Cross Switzerland (GCCH). Our efforts centred on ensuring the safety of drinking water in war-affected areas, as the conflict has caused contamination that poses serious, sometimes life-threatening risk, particularly for children and the elderly. Once again, we are committed to providing effective humanitarian aid in rapidly changing conditions.

The region surrounding Chernobyl has been a priority for GCCH since its inception. Even before the war, the situation there was already precarious. While the contaminated areas in Ukraine are relatively distant from the front lines, they remain vulnerable to missile strikes and other acts of war. As a result, we have shifted our focus in the region from development aid to humanitarian aid.

In Vietnam, we successfully continued and expanded our project work. Decades after the Vietnam War, the effects of Agent Orange still result in hereditary genetic disorders and severe deformities, while support for the victims remains inadequate. GCCH continues to play a vital role in providing ongoing assistance, particularly in orthopaedic care. It is absolutely crucial that artificial limbs and orthopaedic supports are adjusted regularly, especially in the case of children to accommodate their growth.

In 2024, we are prioritizing the expansion of psychological support services. In Ukraine, the psychological toll of the war is becoming increasingly severe, particularly for children and young people. Through our therapy programme, we are bringing light into this darkness. In Vietnam, where people with disabilities are frequently excluded from society and even from family life, we are also working to broaden psychological and social support for those affected by Agent Orange.

The GCCH team would like to extend its heartfelt thanks to everyone who contributed to the success of our aid projects this year, helping us provide meaningful support to countless individuals.

You can read the full Annual Report here.

Please follow and like us: